Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre
Mycoses · 2025-12 · 68 (12)
DOI: 10.1111/myc.70136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, online erschienen am 19.12.2025. Verfasst von Mohammad El-Atoum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Candidemia, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Recent literature indicates a decline in rates of candidemia in the general population.
Objectives
To analyse temporal trends in candidemia among patients with solid tumours and haematological malignancies admitted to a dedicated cancer centre.
Methods
We retrospectively reviewed all episodes of candidemia from July 2008 to June 2020 (12‐year period). The incidence of candidemia was estimated as the number of new cases per 1000 patient days of hospital admission quarterly. A linear regression model was used to analyse changes in incidence rates.
Results
Over a 12‐year period a total of 212 episodes of candidemia were identified with 90 (42.5%) occurring in patients with haematological malignancies and 122 (57.5%) in patients with solid tumours. The overall incidence of candidemia was 0.49 episodes per 1000 patient‐days of admission per quarter. There was a significant decline in the incidence of candidemia overtime for the overall cohort (from 0.81 to 0.21 patient days per quarter, p < 0.001). This decline was statistically significant in patients with solid tumours (from 0.91 to 0.18 patient days per quarter, p < 0.001) with only a downward trend noted in patients with haematological malignancies (from 0.65 to 0.25 patient days per quarter, p = 0.052).
Conclusions
We observed a global decline in episodes of candidemia in patients with malignancies mainly driven by a decrease in patients with solid tumours. Patients with haematological malignancies continue to experience considerable rates of candidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA.
- Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Division of Infectious Diseases, Department of Internal Medicine, Roswell Park Comprehensive Cancer Center and Jacobs School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York, USA.
- Department of Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
- Department of Internal and Hospital Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID-Profile: Nikolaos G Almyroudis
Zitieren
APA
El-Atoum, M., Chen, G. L., Bonnewell, J. P., Segal, B. H., & Almyroudis, N. G. (2025). Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre. Mycoses, 68(12). https://doi.org/10.1111/myc.70136
Vancouver
El-Atoum M, Chen GL, Bonnewell JP, Segal BH, Almyroudis NG. Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre. Mycoses. 2025;68(12). doi:10.1111/myc.70136
BibTeX
@article{ElAtoum2025,
author = {El-Atoum, Mohammad and Chen, George L and Bonnewell, John P and Segal, Brahm H and Almyroudis, Nikolaos G},
title = {Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre},
journal = {Mycoses},
year = {2025},
volume = {68},
number = {12},
doi = {10.1111/myc.70136}
}
EUVIMED